---
document_datetime: 2025-09-30 13:48:02
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/wegovy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: wegovy-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.1468887
conversion_datetime: 2025-12-22 16:48:54.805593
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Wegovy

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                   | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | This was an application for a variation | 25/09/2025                          |                                             | SmPC and PL                      |           |

1  Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions are issued for all other procedures.

2  A Commission decision (CD) is issued for procedures that affect the terms of the marketing authorisation (e.g. summary of product characteristics, annex II, labelling, package leaflet). The CD is issued within two months of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation (EU) No. 712/2012, or within one year for other procedures.

3  SmPC (Summary of Product Characteristics), Annex II, Labelling, PL (Package Leaflet).

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000287437                     | following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. - - Accepted C.I.z - to update sections 4.4 and 4.8 of the SmPC and sections 2 and 4 of the Package Leaflet to include the warning for Non- Arteritic Anterior Ischemic Optic Neuropathy (NAION) in line with the outcome of the Pharmacovigilance Risk Assessment Committee (PRAC) Assessment Report for the Post-Authorisation Measure Procedures EMA/PAM/0000262449, EMA/ PAM/0000262475, and EMA/PAM/0000262468 of PSUR EMEA/H/C/PSUSA/00010671/202405 (1   |            |     |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000275558 | This was an application for a group of variations. B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.z Other changes - Accepted B.II.b.2 Change to importer, batch release arrangements and quality control testing of the finished product - B.II.b.2.a                                                                                                                                                                                                                       | 17/06/2025 | N/A |

<div style=\"page-break-after: always\"></div>

|                                       | Replacement or addition of a site where batch control/testing takes place - Accepted B.II.g.5 Implementation of changes foreseen in an approved change management protocol - B.II.g.5.c Implementation of a change for a biological/immunological medicinal product - Accepted                                                      |            |     |
|---------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000244317 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.z Other changes - Accepted | 10/04/2025 | N/A |
| Variation type IB / EMA/VR/0000246575 | This was an application for a group of variations. B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.2 Including batch control/testing - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the                                  | 19/02/2025 | N/A |

<div style=\"page-break-after: always\"></div>

| manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.z Other changes - Accepted   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|